This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Citing articles on Web of Science (6)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Andrew R. Altman, MD; Jaime A. Tschen, MD; Lawrence Rice, MD

Arch Dermatol. 1989;125(3):394-396.

Abstract
• A patient with malignant carcinoid syndrome was treated with a long-acting somatostatin analogue. The cutaneous and systemic improvement our patient had while receiving this therapy is described.

(Arch Dermatol 1989;125:394-396)

Author Affiliations
From the Departments of Dermatology (Drs Altman and Tschen), Pathology (Dr Tschen), and Internal Medicine (Dr Rice), Baylor College of Medicine, Houston. Dr Altman is in private practice, Sunrise, Fla.

Footnotes
Accepted for publication May 17,1988.

Presented at the 46th Annual Meeting of the American Academy of Dermatology, San Antonio, Tex, Dec 6, 1987.

Reprints not available.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Somatostatin and a Long-Acting Analogue, Octreotide Acetate: Relevance to Dermatology
Camisa
Arch Dermatol 1989;125:407-412.
ABSTRACT